10.03 USD
↘ 0.62 (5.82%)AT CLOSE (03:59 PM EST)
Faeth Therapeutics, Inc. Common Stock
FTHNASDAQ • USD
10.20
↗ 0.17 (1.70%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
10.20
↗ 0.17 (1.70%)
Market: CLOSED
Faeth Therapeutics, Inc. Common Stock (FTH) trades at $10.03 per share. Technical indicators currently signal "Strong Sell". Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, FTH appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 13, 2026.
Open?$10.51
High?$10.63
Low?$9.67
Prev. Close?$10.65
Volume?1.0M
Avg. Volume?593.4K
VWAP?$10.19
Rel. Volume?1.75x
Bid / Ask
Bid?$9.57 × 300
Ask?$13.00 × 1.0K
Spread?$3.43
Midpoint?$11.29
Valuation & Ratios
Market Cap?259.2M
Shares Out?25.8M
Float?11.3M
Float %?43.9%
P/E Ratio?N/A
P/B Ratio?1.61
EPS?-$8.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Employees
29
Market Cap
259.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-02-04
Address
701 TILLERY STREET #12 #1010
AUSTIN, TX 78702
Phone: 512-200-2982
AUSTIN, TX 78702
Phone: 512-200-2982
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestSqueeze Risk
Short % of Float?24.07%Squeeze Risk
Short Interest?2.7M
Days to Cover?6.3
Free Float11.3M
Avg Daily Volume432.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?16.12Strong
Quick Ratio?16.12Strong
Cash Ratio?1.29Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.61CHEAP▾
Peers100
S&P84
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-131.2%WEAK▾
S&P3
ROA?-118.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-43281000
Enterprise Value?$245.0M
Fundamentals ratios updated end of day